Showing results (191-200 of 247) with videos related to
Sort By:
Pageof 25
Cell|March 17, 2023
Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive neurodegenerationSima Khazaei, Carol C L Chen, Augusto Faria Andrade, et al.Nature Medicine|November 18, 2023
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trialLindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford, et al.Cancer Discovery|March 20, 2021
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, et al.The Lancet. Oncology|October 22, 2013
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.Cell|July 10, 2024
TULIPs decorate the three-dimensional genome of PFA ependymomaMichael J Johnston, John J Y Lee, Bo Hu, et al.Cell|January 24, 2012
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutationsTobias Rausch, David T W Jones, Marc Zapatka, et al.Nature Genetics|April 8, 2014
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytomaAdam M Fontebasso, Simon Papillon-Cavanagh, Jeremy Schwartzentruber, et al.Biorxiv : the Preprint Server for Biology|July 3, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric GliomasMaria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, et al.Cancer Discovery|April 4, 2024
The Virtual ChildRichard J Gilbertson, Sam Behjati, Anna-Lisa Böttcher, et al.Nature Cancer|April 15, 2022
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.Pageof 25